BE888290A - Acide 3,7,11,15-tetramethyl-2,4.6.10.14-hexadecapentaenoique, - Google Patents

Acide 3,7,11,15-tetramethyl-2,4.6.10.14-hexadecapentaenoique,

Info

Publication number
BE888290A
BE888290A BE2/59103A BE2059103A BE888290A BE 888290 A BE888290 A BE 888290A BE 2/59103 A BE2/59103 A BE 2/59103A BE 2059103 A BE2059103 A BE 2059103A BE 888290 A BE888290 A BE 888290A
Authority
BE
Belgium
Prior art keywords
hexadecapentaenoique
tetramethyl
acid
Prior art date
Application number
BE2/59103A
Other languages
English (en)
French (fr)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of BE888290A publication Critical patent/BE888290A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE2/59103A 1980-04-07 1981-04-06 Acide 3,7,11,15-tetramethyl-2,4.6.10.14-hexadecapentaenoique, BE888290A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4455880A JPS56140949A (en) 1980-04-07 1980-04-07 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenic acid

Publications (1)

Publication Number Publication Date
BE888290A true BE888290A (fr) 1981-07-31

Family

ID=12694821

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2/59103A BE888290A (fr) 1980-04-07 1981-04-06 Acide 3,7,11,15-tetramethyl-2,4.6.10.14-hexadecapentaenoique,

Country Status (5)

Country Link
US (2) US4988732A (enExample)
JP (1) JPS56140949A (enExample)
AT (1) AT374781B (enExample)
BE (1) BE888290A (enExample)
PH (1) PH16454A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6160612A (ja) * 1984-08-31 1986-03-28 Eisai Co Ltd 制癌効果増強剤
JPH075460B2 (ja) * 1985-02-22 1995-01-25 エーザイ株式会社 制癌剤
JPH10167960A (ja) * 1996-12-12 1998-06-23 Les-Bell:Kk 肝細胞ガン再発抑制剤
CA2306525C (en) 1999-04-23 2009-06-23 Nikken Chemicals Co., Ltd. Method for purification of polyprenyl compounds
CA2407421C (en) * 2000-04-24 2009-11-03 Nikken Chemicals Co., Ltd. Activators of peroxisome proliferator-activated receptors
EP1506778B1 (en) * 2002-05-17 2014-03-26 Kowa Company, Ltd. TGF-a EXPRESSION INHIBITORS
US7314643B2 (en) 2002-08-20 2008-01-01 Nikken Chemicals Co., Ltd. Soft capsule preparation
JP4520203B2 (ja) * 2003-04-18 2010-08-04 興和株式会社 ポリプレニル系化合物の製造方法
JP4886506B2 (ja) * 2004-02-25 2012-02-29 国立大学法人 東京大学 転写因子ｋｌｆ５の活性化抑制作用を有する医薬
US20080200733A1 (en) * 2005-07-06 2008-08-21 Nicholas Piramal India Limited Processes For The Preparation Of Purified Solanesol, Solanesyl Bromide & Solanesyl Acetone
WO2008126363A1 (ja) 2007-03-30 2008-10-23 Kowa Company, Ltd. 脂肪肝又は非アルコール性脂肪性肝炎の予防及び／又は治療のための医薬
US20100184859A1 (en) 2007-06-21 2010-07-22 Josai University Educational Corporation Medicament having promoting action on hepatocyte proliferation
US8846961B2 (en) * 2010-10-01 2014-09-30 Dsm Ip Assets B.V. Synthesis of peretinoin
CN103153936B (zh) * 2010-10-01 2016-08-03 帝斯曼知识产权资产管理有限公司 改进的培瑞维a酸的合成
JP7655479B2 (ja) 2020-11-20 2025-04-02 国立研究開発法人国立長寿医療研究センター ［１１ｃ］標識非環式レチノイド、中枢神経系活性化剤及びそれらの製造方法。

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2329656A1 (fr) * 1975-10-30 1977-05-27 Hoffmann La Roche Procede de preparation de composes polyeniques, en particulier de carotenoides et de vitamine a
JPS52144614A (en) * 1976-05-27 1977-12-02 Eisai Co Ltd Polyprenyl carboxylic acid compounds and hypo-tensor containing same
JPS601283B2 (ja) * 1976-06-08 1985-01-14 帝人株式会社 包接化合物並びにその製造法
DE3113149A1 (de) * 1980-04-07 1982-01-28 Eisai Co Ltd 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensaeure, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung als antikrebsmittel und therapeutisches mittel fuer die behandlung von hauterkrankungen
JPS5731615A (en) * 1980-07-31 1982-02-20 Eisai Co Ltd Remedy for skin disease with keratinization

Also Published As

Publication number Publication date
AT374781B (de) 1984-05-25
ATA161381A (de) 1983-10-15
JPS56140949A (en) 1981-11-04
JPS6332058B2 (enExample) 1988-06-28
PH16454A (en) 1983-10-13
US4988732A (en) 1991-01-29
US4917829A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
DE3372483D1 (de) 1,3-dioxan-5-ylalkenoic acids
NO811304L (no) Blyerstatning.
IT8119459A0 (it) 25-idrossi-26,26,26,27,27,27-esaflu orocolecalciferolo.
FI812270A7 (fi) Tulehduksenvastaiset 4,5-diaryyli- - polyfluorialkyyli-1H- imidatsoli-2-metaaniamiinit.
PH16454A (en) 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
ATE8631T1 (de) 1,1,1',1'-tetraoxo-penicillanoyloxymethylpenicillanat.
FI811191L (fi) Antiinflammatoriska 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-metanaminer
IT8120967A0 (it) Acido 3, 7, 11, 15-tetrametil-2, 4, 6, 10, 14-esadecapentaenoico.
IT8121126A0 (it) 1 alfa-idrossi-2beta-fluorocolecalciferolo.
NO155881C (no) Amfotert fettsyrekompleks.
ES505456A0 (es) Procedimiento para preparar 1-azabiciclo(3.3.0)octano-2,8- diona
DK155594C (da) 3,3-dimethyl-1-phenoxybutan-2-oler
DK167182A (da) 5,6-o-isoalkylidenascorbinsyrederivater
IT1136980B (it) "17-sostituiti solfonil-16,16-disostituiti androsteni"
NL7901453A (nl) Gesubstitueerd imidazolidinyl-3-chloor-3-cephem-4-car- bonzuur.
ATE24476T1 (de) 1,3-dihalopropan-2-ole.
FI810242A7 (fi) 1,3-diformyylioksi-2-bromi-2- nitropropaani.
NL7812598A (nl) Thioalkanoylalkaancarbonzuurverbindingen.
IT1189011B (it) 1,4;3,6-dinanidro-2,5-diazido-2,5-dideossi-esitoli
DK490681A (da) Dioxolan-substituerede 2,6-dinitroaniliner
ATE6059T1 (de) Entzuendungshemmende 4,5-diaryl-alpha(polyfluoralkyl)-1h-pyrrol-2-methanamine.
FI882335L (fi) Fodertillsatsaemne innehaollande 1-cyklopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazinkinolin-3 -karboxylsyra.
FI854743A7 (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara substituerade acylderivat av oktahydro-1h-indol-2-karboxylsyra.
ATE10092T1 (de) Entzuendungshemmende 4,5-diaryl-alphapolyfluoralkyl-1h-imidazol-2-methanamine.
IT8219750A0 (it) 3,4-diidro-2-metil-4-osso-2h-1,3-be nzotiazina-3-acido carbossilico 1,1-diossido.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EISAI CO. LTD

Effective date: 19980430